Paliperidone is available in a long-acting injectable form known as paliperidone palmitate, which is administered once every four to six weeks. This extended-release formulation allows for a sustained release of the medication into the bloodstream, providing continuous therapeutic effects and reducing the frequency of administration compared to oral medications.
